Accessibility Statement Skip Navigation
  • Resources
  • Investor Relations
  • Journalists
  • Agencies
  • Client Login
  • Send a Release
Return to PR Newswire homepage
  • News
  • Products
  • Contact
Search
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News Releases view all

    • News in Focus
        • Browse News Releases

        • All News Releases
        • All Public Company
        • English-only
        • News Releases Overview

        • Multimedia Gallery

        • All Multimedia
        • All Photos
        • All Videos
        • Multimedia Gallery Overview

        • Trending Topics

        • All Trending Topics
    • Business & Money
        • Auto & Transportation

        • Aerospace, Defense
        • Air Freight
        • Airlines & Aviation
        • Automotive
        • Maritime & Shipbuilding
        • Railroads and Intermodal Transportation
        • Supply Chain/Logistics
        • Transportation, Trucking & Railroad
        • Travel
        • Trucking and Road Transportation
        • Auto & Transportation Overview

        • View All Auto & Transportation

        • Business Technology

        • Blockchain
        • Broadcast Tech
        • Computer & Electronics
        • Computer Hardware
        • Computer Software
        • Data Analytics
        • Electronic Commerce
        • Electronic Components
        • Electronic Design Automation
        • Financial Technology
        • High Tech Security
        • Internet Technology
        • Nanotechnology
        • Networks
        • Peripherals
        • Semiconductors
        • Business Technology Overview

        • View All Business Technology

        • Entertain­ment & Media

        • Advertising
        • Art
        • Books
        • Entertainment
        • Film and Motion Picture
        • Magazines
        • Music
        • Publishing & Information Services
        • Radio & Podcast
        • Television
        • Entertainment & Media Overview

        • View All Entertain­ment & Media

        • Financial Services & Investing

        • Accounting News & Issues
        • Acquisitions, Mergers and Takeovers
        • Banking & Financial Services
        • Bankruptcy
        • Bond & Stock Ratings
        • Conference Call Announcements
        • Contracts
        • Cryptocurrency
        • Dividends
        • Earnings
        • Earnings Forecasts & Projections
        • Financing Agreements
        • Insurance
        • Investments Opinions
        • Joint Ventures
        • Mutual Funds
        • Private Placement
        • Real Estate
        • Restructuring & Recapitalization
        • Sales Reports
        • Shareholder Activism
        • Shareholder Meetings
        • Stock Offering
        • Stock Split
        • Venture Capital
        • Financial Services & Investing Overview

        • View All Financial Services & Investing

        • General Business

        • Awards
        • Commercial Real Estate
        • Corporate Expansion
        • Earnings
        • Environmental, Social and Governance (ESG)
        • Human Resource & Workforce Management
        • Licensing
        • New Products & Services
        • Obituaries
        • Outsourcing Businesses
        • Overseas Real Estate (non-US)
        • Personnel Announcements
        • Real Estate Transactions
        • Residential Real Estate
        • Small Business Services
        • Socially Responsible Investing
        • Surveys, Polls and Research
        • Trade Show News
        • General Business Overview

        • View All General Business

    • Science & Tech
        • Consumer Technology

        • Artificial Intelligence
        • Blockchain
        • Cloud Computing/Internet of Things
        • Computer Electronics
        • Computer Hardware
        • Computer Software
        • Consumer Electronics
        • Cryptocurrency
        • Data Analytics
        • Electronic Commerce
        • Electronic Gaming
        • Financial Technology
        • Mobile Entertainment
        • Multimedia & Internet
        • Peripherals
        • Social Media
        • STEM (Science, Tech, Engineering, Math)
        • Supply Chain/Logistics
        • Wireless Communications
        • Consumer Technology Overview

        • View All Consumer Technology

        • Energy & Natural Resources

        • Alternative Energies
        • Chemical
        • Electrical Utilities
        • Gas
        • General Manufacturing
        • Mining
        • Mining & Metals
        • Oil & Energy
        • Oil and Gas Discoveries
        • Utilities
        • Water Utilities
        • Energy & Natural Resources Overview

        • View All Energy & Natural Resources

        • Environ­ment

        • Conservation & Recycling
        • Environmental Issues
        • Environmental Policy
        • Environmental Products & Services
        • Green Technology
        • Natural Disasters
        • Environment Overview

        • View All Environ­ment

        • Heavy Industry & Manufacturing

        • Aerospace & Defense
        • Agriculture
        • Chemical
        • Construction & Building
        • General Manufacturing
        • HVAC (Heating, Ventilation and Air-Conditioning)
        • Machinery
        • Machine Tools, Metalworking and Metallurgy
        • Mining
        • Mining & Metals
        • Paper, Forest Products & Containers
        • Precious Metals
        • Textiles
        • Tobacco
        • Heavy Industry & Manufacturing Overview

        • View All Heavy Industry & Manufacturing

        • Telecomm­unications

        • Carriers and Services
        • Mobile Entertainment
        • Networks
        • Peripherals
        • Telecommunications Equipment
        • Telecommunications Industry
        • VoIP (Voice over Internet Protocol)
        • Wireless Communications
        • Telecommunications Overview

        • View All Telecomm­unications

    • Lifestyle & Health
        • Consumer Products & Retail

        • Animals & Pets
        • Beers, Wines and Spirits
        • Beverages
        • Bridal Services
        • Cannabis
        • Cosmetics and Personal Care
        • Fashion
        • Food & Beverages
        • Furniture and Furnishings
        • Home Improvement
        • Household, Consumer & Cosmetics
        • Household Products
        • Jewelry
        • Non-Alcoholic Beverages
        • Office Products
        • Organic Food
        • Product Recalls
        • Restaurants
        • Retail
        • Supermarkets
        • Toys
        • Consumer Products & Retail Overview

        • View All Consumer Products & Retail

        • Entertain­ment & Media

        • Advertising
        • Art
        • Books
        • Entertainment
        • Film and Motion Picture
        • Magazines
        • Music
        • Publishing & Information Services
        • Radio & Podcast
        • Television
        • Entertainment & Media Overview

        • View All Entertain­ment & Media

        • Health

        • Biometrics
        • Biotechnology
        • Clinical Trials & Medical Discoveries
        • Dentistry
        • FDA Approval
        • Fitness/Wellness
        • Health Care & Hospitals
        • Health Insurance
        • Infection Control
        • International Medical Approval
        • Medical Equipment
        • Medical Pharmaceuticals
        • Mental Health
        • Pharmaceuticals
        • Supplementary Medicine
        • Health Overview

        • View All Health

        • Sports

        • General Sports
        • Outdoors, Camping & Hiking
        • Sporting Events
        • Sports Equipment & Accessories
        • Sports Overview

        • View All Sports

        • Travel

        • Amusement Parks and Tourist Attractions
        • Gambling & Casinos
        • Hotels and Resorts
        • Leisure & Tourism
        • Outdoors, Camping & Hiking
        • Passenger Aviation
        • Travel Industry
        • Travel Overview

        • View All Travel

    • Policy & Public Interest
        • Policy & Public Interest

        • Advocacy Group Opinion
        • Animal Welfare
        • Congressional & Presidential Campaigns
        • Corporate Social Responsibility
        • Domestic Policy
        • Economic News, Trends, Analysis
        • Education
        • Environmental
        • European Government
        • FDA Approval
        • Federal and State Legislation
        • Federal Executive Branch & Agency
        • Foreign Policy & International Affairs
        • Homeland Security
        • Labor & Union
        • Legal Issues
        • Natural Disasters
        • Not For Profit
        • Patent Law
        • Public Safety
        • Trade Policy
        • U.S. State Policy
        • Policy & Public Interest Overview

        • View All Policy & Public Interest

    • People & Culture
        • People & Culture

        • Aboriginal, First Nations & Native American
        • African American
        • Asian American
        • Children
        • Diversity, Equity & Inclusion
        • Hispanic
        • Lesbian, Gay & Bisexual
        • Men's Interest
        • People with Disabilities
        • Religion
        • Senior Citizens
        • Veterans
        • Women
        • People & Culture Overview

        • View All People & Culture

    • Explore Our Platform
    • Plan Campaigns
    • Create with AI
    • Distribute Press Releases
    • Report Results
    • Amplify Content
    • All Products
    • General Inquiries
    • Editorial Bureaus
    • Partnerships
    • Media Inquiries
    • Worldwide Offices
    • Hamburger menu
    • PR Newswire: news distribution, targeting and monitoring
    • Send a Release
      • ALL CONTACT INFO
      • Contact Us

        888-776-0942
        from 8 AM - 10 PM ET

    • Searching for your content...

      No results found. Please change your search terms and try again.

      News Releases

      view all
      Close menu
    • News
    • Products
    • Contact
      • Send a Release
      • Client Login
      • Resources
      • Blog
      • Journalists
      • RSS
      • 3 News in Focus
      • 5 Business & Money
      • 5 Science & Tech
      • 5 Lifestyle & Health
      • 1 Policy & Public Interest
      • 1 People & Culture
      • Send a Release
      • Client Login
      • Resources
      • Blog
      • Journalists
      • RSS
      • Explore Our Platform
      • Plan Campaigns
      • Create with AI
      • Distribute Press Releases
      • Report Results
      • Amplify Content
      • All Products
      • Send a Release
      • Client Login
      • Resources
      • Blog
      • Journalists
      • RSS
      • General Inquiries
      • Editorial Bureaus
      • Partnerships
      • Media Inquiries
      • Worldwide Offices
      • Send a Release
      • Client Login
      • Resources
      • Blog
      • Journalists
      • RSS
      Close submenu (News in Focus) News in Focus
      • Browse News Releases
      • Multimedia Gallery
      • Trending Topics
      Close submenu (Business & Money) Business & Money
      • Auto & Transportation
      • Business Technology
      • Entertain­ment & Media
      • Financial Services & Investing
      • General Business
      Close submenu (Science & Tech) Science & Tech
      • Consumer Technology
      • Energy & Natural Resources
      • Environ­ment
      • Heavy Industry & Manufacturing
      • Telecomm­unications
      Close submenu (Lifestyle & Health) Lifestyle & Health
      • Consumer Products & Retail
      • Entertain­ment & Media
      • Health
      • Sports
      • Travel
      Close submenu (Policy & Public Interest) Policy & Public Interest
      • Policy & Public Interest
      Close submenu (People & Culture) People & Culture
      • People & Culture

      Castlight Health Announces Second Quarter 2019 Results

      Updates Full Year 2019 Guidance & Announces Management Changes

      Castlight Logo (PRNewsfoto/Castlight Health)

      News provided by

      Castlight Health, Inc.

      Jul 30, 2019, 16:20 ET

      Share this article

      Share this article


      SAN FRANCISCO, July 30, 2019 /PRNewswire/ -- Castlight Health, Inc. (NYSE:CSLT), a leading health benefits platform provider, today announced results for its second quarter ended June 30, 2019 and updated guidance for full year 2019. The Company also announced today that John Doyle has stepped down from his roles as chief executive officer and director. The Castlight board of directors has appointed Maeve O'Meara, formerly executive vice president of product and customer experience, as Castlight's chief executive officer and director, effective immediately. Additionally, Siobhan Nolan Mangini has been promoted to president and will also continue to serve as chief financial officer.

      "From the time Maeve joined Castlight in 2010, her excellence across product development and customer relationships has impressed all of us on the board of directors. These skills, combined with the vision and leadership she's exhibited as executive vice president make her the natural choice to become Castlight's CEO," said Bryan Roberts, co-founder and chairman of Castlight Health. "We are confident in Maeve's ability to execute on our strategic and financial goals, and I look forward to working closely with her to help Castlight accomplish its mission of simplifying and improving healthcare."

      "I'm excited to lead Castlight, given the strength of our team and technology, and I believe our assets put us in position to improve the cost, quality and consumer experience issues across US healthcare," said Maeve O'Meara, chief executive officer of Castlight Health. "We will continue to focus on partnering with our core employer buyers in order to create more value for them in their workforce, but we also have a clear opportunity to leverage our data and technology assets more broadly. By expanding our channel strategy to power user experiences outside of our own applications, we believe we can expand our addressable market and make a greater impact across the healthcare ecosystem."

      For more information on Maeve O'Meara and Siobhan Nolan Mangini, please refer to the press release entitled "Castlight Health Announces Key Management Changes" published today.

      Financial performance for the three months ended June 30, 2019 compared to the three months ended June 30, 2018 includes:

      • GAAP total revenue of $35.9 million, representing a decrease of 5%
      • GAAP gross margin of 60.6%, compared to 58.4%
      • Non-GAAP gross margin of 63.4%, compared to 62.2%
      • GAAP operating loss of $8.6 million, compared to a loss of $14.1 million
      • Non-GAAP operating loss of $2.9 million, compared to $6.9 million
      • GAAP net loss per basic and diluted share of $0.06, compared to a net loss per basic and diluted share of $0.10
      • Non-GAAP net loss per basic and diluted share of $0.02, compared to a net loss per basic and diluted share of $0.05
      • Cash used in operations of $1.8 million, compared to $1.1 million

      Total cash, cash equivalents and marketable securities was $63.9 million as of June 30, 2019.

      A reconciliation of GAAP to non-GAAP results has been provided in this press release in the accompanying tables. An explanation of these measures is also included below under the heading "Non-GAAP Financial Measures."

      Business Outlook

      The Company is updating its previously-issued 2019 outlook. For the full year 2019, the Company now expects:

      • GAAP revenue in the range of $140 million to $145 million
      • Non-GAAP operating loss in the range of $8 million to $13 million
      • Non-GAAP net loss per share of approximately $0.06 to $0.09 based on approximately 145 million to 146 million shares

      Quarterly Conference Call

      Castlight Health senior management will host a conference call to discuss its second quarter 2019 results and business outlook today at 2:00 p.m. Pacific Time (5:00 p.m. Eastern Time). A live audio webcast of the conference call, together with detailed financial information, can be accessed through the Company's Investor Relations website at http://ir.castlighthealth.com. An archive of the webcast can also be accessed through the same link. The live conference call can be accessed by dialing (833) 238-7953 and the replay will be available for one week at (800) 585-8367.  The conference ID number for the live call and replay is 2365013.

      About Castlight Health

      Castlight is on a mission to make it as easy as humanly possible to navigate healthcare and live happier, healthier, more productive lives. Our health navigation platform connects with hundreds of health vendors, benefits resources, and plan designs, giving rise to the world's first comprehensive app for all health needs. We guide individuals-based on their unique profile- to the best resources available to them, whether they are healthy, chronically ill, or actively seeking medical care. In doing so, we help companies regain control over rising healthcare costs and get more value from their benefits investments. Castlight revolutionized the healthcare sector with the introduction of data-driven price transparency tools in 2008 and the first consumer-grade wellbeing platform in 2012. Today, Castlight serves as the health navigation platform for millions of people and is a trusted partner to many of the largest employers in the world.

      For more information visit www.castlighthealth.com. Follow us on Twitter and LinkedIn and Like us on Facebook.

      Non-GAAP Financial Measures

      To supplement Castlight Health's financial statements presented in accordance with generally accepted accounting principles (GAAP), we also use and provide investors and others with non-GAAP measures of certain components of financial performance, including non-GAAP gross profit and margin, non-GAAP operating expense, non-GAAP operating income (loss), non-GAAP net income (loss) and non-GAAP net income (loss) per share. Non-GAAP gross profit and margin, non-GAAP operating expense, non-GAAP operating income (loss), and non-GAAP net income (loss) exclude stock-based compensation, certain legal expenses, amortization of intangibles, amortization of internal-use software, and lease exit and related charges.

      We believe that these non-GAAP financial measures provide useful supplemental information to investors and others, facilitate the analysis of the company's core operating results and comparison of operating results across reporting periods, and can help enhance overall understanding of the company's historical financial performance.

      We have provided a reconciliation of each non-GAAP financial measure to the most directly comparable GAAP financial measure, except that we have not reconciled our non-GAAP operating loss and net loss per share guidance for the full year 2019 to comparable GAAP measures because we do not provide guidance for stock-based compensation expense, and capitalization and amortization of internal-use software, which are reconciling items between GAAP and non-GAAP. The factors that may impact our future stock-based compensation expense, and capitalization and amortization of internal-use software are out of our control and/or cannot be reasonably predicted, and therefore we are unable to provide such guidance without unreasonable effort. Factors include our market capitalization and related volatility of our stock price and our inability to project the cost or scope of internally produced software.

      These non-GAAP financial measures should be considered in addition to, not as a substitute for or in isolation from, measures prepared in accordance with GAAP.

      Further, these non-GAAP measures may differ from the non-GAAP information used by other companies, including peer companies, and therefore comparability may be limited. Castlight Health encourages investors and others to review the company's financial information in its entirety and not rely on a single financial measure.

      Safe Harbor for Forward-Looking Statements

      This press release contains forward-looking statements about Castlight Health's expectations, plans, intentions, and strategies, including, but not limited to, statements regarding Castlight Health's second quarter performance and 2019 full year projections, executive leadership, the success of our strategy and our expectations for our future business and financial performance. Statements including words such as "anticipate," "believe," "estimate," "will," "continue," "expect," or "future," and statements in the future tense are forward-looking statements. These forward-looking statements involve risks and uncertainties, as well as assumptions, which, if they do not fully materialize or prove incorrect, could cause our results to differ materially from those expressed or implied by such forward-looking statements. The risks and uncertainties include those described in Castlight Health's documents filed with or furnished to the Securities and Exchange Commission, including the risks set forth in our quarterly report on Form 10-Q for the three months ended June 30, 2019. All forward-looking statements in this press release are based on information available to Castlight Health as of the date hereof. Castlight Health assumes no obligation to update these forward-looking statements.

      Copyright 2019 Castlight Health, Inc. Castlight Health® is the registered trademark of Castlight Health, Inc. Other company and product names may be trademarks of the respective companies with which they are associated.

      CASTLIGHT HEALTH, INC.

      CONDENSED CONSOLIDATED BALANCE SHEETS

      (In thousands)

      (unaudited)



      As of


      June 30, 2019


      December 31, 2018

      Assets




      Current assets:




      Cash and cash equivalents

      $

      50,052



      $

      66,005


      Marketable securities

      13,874



      11,327


      Accounts receivable and other, net

      32,611



      26,816


      Prepaid expenses and other current assets

      5,450



      3,680


      Total current assets

      101,987



      107,828


      Property and equipment, net

      3,556



      3,963


      Restricted cash, non-current

      1,325



      1,325


      Deferred commissions

      17,956



      20,142


      Deferred professional service costs

      9,093



      10,133


      Intangible assets, net

      14,457



      16,209


      Goodwill

      91,785



      91,785


      Operating lease right-of-use assets, net

      14,691



      —


      Other assets

      2,223



      2,129


      Total assets

      $

      257,073



      $

      253,514


      Liabilities and stockholders' equity




      Current liabilities:




      Accounts payable

      $

      11,355



      $

      9,556


      Accrued expenses and other current liabilities

      11,170



      15,454


      Accrued compensation

      5,169



      5,975


      Deferred revenue

      20,698



      20,193


      Operating lease liabilities

      5,911



      —


      Total current liabilities

      54,303



      51,178


      Deferred revenue, non-current

      837



      1,030


      Debt, non-current

      2,324



      3,254


      Operating lease liabilities, non-current

      12,032



      —


      Other liabilities, non-current

      1,067



      3,381


      Total liabilities

      70,563



      58,843


      Stockholders' equity

      186,510



      194,671


      Total liabilities and stockholders' equity

      $

      257,073



      $

      253,514


      CASTLIGHT HEALTH, INC.

      CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS

      (In thousands, except per share data)

      (unaudited)



      Three Months Ended June 30,


      Six Months Ended June 30,


      2019


      2018


      2019


      2018

      Revenue:








      Subscription

      $

      33,964



      $

      34,802



      $

      67,770



      $

      67,791


      Professional services and other

      1,946



      2,982



      3,630



      6,472


      Total revenue, net

      35,910



      37,784



      71,400



      74,263


      Cost of revenue:








      Cost of subscription(1)

      8,234



      9,140



      16,400



      18,314


      Cost of professional services and other(1)

      5,929



      6,590



      11,873



      12,359


      Total cost of revenue

      14,163



      15,730



      28,273



      30,673


      Gross profit

      21,747



      22,054



      43,127



      43,590


      Operating expenses:








      Sales and marketing(1)

      8,889



      13,306



      18,104



      27,218


      Research and development(1)

      14,487



      16,425



      30,212



      31,796


      General and administrative(1)

      7,010



      6,382



      14,303



      13,207


      Total operating expenses

      30,386



      36,113



      62,619



      72,221


      Operating loss

      (8,639)



      (14,059)



      (19,492)



      (28,631)


      Other income, net

      258



      101



      572



      229


      Net loss

      $

      (8,381)



      $

      (13,958)



      $

      (18,920)



      $

      (28,402)


      Net loss per share, basic and diluted

      $

      (0.06)



      $

      (0.10)



      $

      (0.13)



      $

      (0.21)


      Weighted-average shares used to compute basic and diluted net loss per share

      144,572



      136,682



      143,790



      135,843



      (1)  Includes stock-based compensation expense as follows:



      Three Months Ended June 30,


      Six Months Ended June 30,


      2019


      2018


      2019


      2018

      Cost of revenue:








      Cost of subscription

      $

      196



      $

      231



      $

      415



      $

      473


      Cost of professional services and other

      236



      315



      501



      616


      Sales and marketing

      662



      1,318



      1,289



      2,456


      Research and development

      1,733



      1,908



      3,437



      3,562


      General and administrative

      2,030



      1,375



      3,192



      2,632


      CASTLIGHT HEALTH, INC.

      CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS

      (In thousands)

      (unaudited)



      Three Months Ended June 30,


      Six Months Ended June 30,


      2019


      2018


      2019


      2018

      Operating activities:








      Net loss

      $

      (8,381)



      $

      (13,958)



      $

      (18,920)



      $

      (28,402)


      Adjustments to reconcile net loss to net cash used in operating activities:








      Depreciation and amortization

      1,343



      1,713



      2,687



      3,573


      Stock-based compensation

      4,857



      5,147



      8,834



      9,739


      Amortization of deferred commissions

      2,365



      2,947



      4,856



      5,800


      Amortization of deferred professional service costs

      1,045



      1,151



      2,014



      2,097


      Non-cash operating lease expense

      1,298



      —



      2,580



      —


      Lease exit and related charges

      —



      901



      —



      1,817


      Accretion and amortization of marketable securities

      (87)



      (135)



      (213)



      (266)


      Changes in operating assets and liabilities:








      Accounts receivable and other, net

      2,088



      4,944



      (5,795)



      (6,252)


      Deferred commissions

      (1,254)



      (1,808)



      (2,670)



      (2,979)


      Deferred professional service costs

      (432)



      (647)



      (901)



      (1,389)


      Prepaid expenses and other assets

      (1,113)



      (2,102)



      (1,864)



      (1,896)


      Accounts payable

      2,713



      (1,272)



      1,864



      511


      Operating lease liabilities

      (1,413)



      —



      (2,795)



      —


      Accrued expenses and other liabilities

      (1,827)



      4,419



      (3,131)



      3,182


      Deferred revenue

      (3,183)



      (4,393)



      312



      (1,210)


      Accrued compensation

      164



      1,979



      (806)



      (4,411)


      Net cash used in operating activities

      (1,817)



      (1,114)



      (13,948)



      (20,086)


      Investing activities:








      Purchase of property and equipment

      (389)



      (916)



      (593)



      (1,304)


      Purchase of marketable securities

      (13,780)



      (13,954)



      (13,780)



      (23,979)


      Maturities of marketable securities

      —



      10,700



      11,453



      26,450


      Net cash (used in) provided by investing activities

      (14,169)



      (4,170)



      (2,920)



      1,167


      Financing activities:








      Proceeds from exercise of stock options

      165



      1,752



      1,845



      2,242


      Principal payments on long-term debt

      (465)



      —



      (930)



      —


      Net cash (used in) provided by financing activities

      (300)



      1,752



      915



      2,242










      Net decrease in cash, cash equivalents and restricted cash

      (16,286)



      (3,532)



      (15,953)



      (16,677)


      Cash, cash equivalents and restricted cash at beginning of period

      67,663



      49,499



      67,330



      62,644


      Cash, cash equivalents and restricted cash at end of period

      $

      51,377



      $

      45,967



      $

      51,377



      $

      45,967










      Reconciliation of cash, cash equivalents and restricted cash:








      Cash and cash equivalents

      $

      50,052



      $

      44,642



      $

      50,052



      $

      44,642


      Restricted cash

      1,325



      1,325



      1,325



      1,325


      Total cash, cash equivalents and restricted cash

      $

      51,377



      $

      45,967



      $

      51,377



      $

      45,967


      CASTLIGHT HEALTH, INC.

      RECONCILIATION OF GAAP TO NON-GAAP FINANCIAL MEASURES

      (In thousands, except per share data)

      (unaudited)



      Three Months Ended


      Six Months Ended


      June 30, 2019


      March 31, 2019


      June 30, 2018


      June 30, 2019


      June 30, 2018

      Gross profit:










      GAAP gross profit subscription

      $

      25,730



      $

      25,640



      $

      25,662



      $

      51,370



      $

      49,477


      Stock-based compensation

      196



      219



      231



      415



      473


      Amortization of internal-use software

      —



      —



      219



      —



      438


      Amortization of intangibles

      587



      587



      678



      1,174



      1,356


      Non-GAAP gross profit subscription

      $

      26,513



      $

      26,446



      $

      26,790



      $

      52,959



      $

      51,744


      GAAP gross margin subscription

      75.8

      %


      75.8

      %


      73.7

      %


      75.8

      %


      73.0

      %

      Non-GAAP gross margin subscription

      78.1

      %


      78.2

      %


      77.0

      %


      78.1

      %


      76.3

      %











      GAAP gross loss professional services

      $

      (3,983)



      $

      (4,260)



      $

      (3,608)



      $

      (8,243)



      $

      (5,887)


      Stock-based compensation

      236



      265



      315



      501



      616


      Non-GAAP gross loss professional services

      $

      (3,747)



      $

      (3,995)



      $

      (3,293)



      $

      (7,742)



      $

      (5,271)


      GAAP gross margin professional services

      (205)

      %


      (253)

      %


      (121)

      %


      (227)

      %


      (91.0)

      %

      Non-GAAP gross margin professional services

      (193)

      %


      (237)

      %


      (110)

      %


      (213)

      %


      (81.4)

      %











      GAAP gross profit

      $

      21,747



      $

      21,380



      $

      22,054



      $

      43,127



      $

      43,590


      Impact of non-GAAP adjustments

      1,019



      1,071



      1,443



      2,090



      2,883


      Non-GAAP gross profit

      $

      22,766



      $

      22,451



      $

      23,497



      $

      45,217



      $

      46,473


      GAAP gross margin

      60.6

      %


      60.2

      %


      58.4

      %


      60.4

      %


      58.7

      %

      Non-GAAP gross margin

      63.4

      %


      63.3

      %


      62.2

      %


      63.3

      %


      62.6

      %











      Operating expense:










      GAAP sales and marketing

      $

      8,889



      $

      9,215



      $

      13,306



      $

      18,104



      $

      27,218


      Stock-based compensation

      (662)



      (627)



      (1,318)



      (1,289)



      (2,456)


      Amortization of intangibles

      (272)



      (272)



      (273)



      (544)



      (721)


      Non-GAAP sales and marketing

      $

      7,955



      $

      8,316



      $

      11,715



      $

      16,271



      $

      24,041












      GAAP research and development

      $

      14,487



      $

      15,725



      $

      16,425



      $

      30,212



      $

      31,796


      Stock-based compensation

      (1,733)



      (1,704)



      (1,908)



      (3,437)



      (3,562)


      Certain legal expenses

      —



      (191)



      —



      (191)



      —


      Lease exit and related charges

      —



      —



      (842)



      —



      (1,758)


      Non-GAAP research and development

      $

      12,754



      $

      13,830



      $

      13,675



      $

      26,584



      $

      26,476












      GAAP general and administrative

      $

      7,010



      $

      7,293



      $

      6,382



      $

      14,303



      $

      13,207


      Stock-based compensation

      (2,030)



      (1,162)



      (1,375)



      (3,192)



      (2,632)


      Amortization of intangibles

      (17)



      (17)



      (17)



      (34)



      (34)


      Certain legal expenses

      —



      (533)



      —



      (533)



      —


      Non-GAAP general and administrative

      $

      4,963



      $

      5,581



      $

      4,990



      $

      10,544



      $

      10,541












      GAAP operating expense

      $

      30,386



      $

      32,233



      $

      36,113



      $

      62,619



      $

      72,221


      Impact of non-GAAP adjustments

      (4,714)



      (4,506)



      (5,733)



      (9,220)



      (11,163)


      Non-GAAP operating expense

      $

      25,672



      $

      27,727



      $

      30,380



      $

      53,399



      $

      61,058












      Operating loss:










      GAAP operating loss

      $

      (8,639)



      $

      (10,853)



      $

      (14,059)



      $

      (19,492)



      $

      (28,631)


      Impact of non-GAAP adjustments

      5,733



      5,577



      7,176



      11,310



      14,046


      Non-GAAP operating loss

      $

      (2,906)



      $

      (5,276)



      $

      (6,883)



      $

      (8,182)



      $

      (14,585)












      Net loss and net loss per share:










      GAAP net loss

      $

      (8,381)



      $

      (10,539)



      $

      (13,958)



      $

      (18,920)



      $

      (28,402)


      Total pre-tax impact of non-GAAP adjustments

      5,733



      5,577



      7,176



      11,310



      14,046


      Non-GAAP net loss

      $

      (2,648)



      $

      (4,962)



      $

      (6,782)



      $

      (7,610)



      $

      (14,356)


      GAAP net loss per share, basic and diluted

      $

      (0.06)



      $

      (0.07)



      $

      (0.10)



      $

      (0.13)



      $

      (0.21)


      Non-GAAP net loss per share, basic and diluted

      $

      (0.02)



      $

      (0.03)



      $

      (0.05)



      $

      (0.05)



      $

      (0.11)


      Shares used in basic and diluted net loss per share computation

      144,572



      143,000



      136,682



      143,790



      135,843


      Castlight Media Contact:
      Courtney Lamie
      [email protected]
      276-492-4248

      Castlight Investor Contact:
      Gary J. Fuges, CFA
      [email protected]
      415-829-1680

      SOURCE Castlight Health, Inc.

      Modal title

      Contact PR Newswire

      • Call PR Newswire at 888-776-0942
        from 8 AM - 9 PM ET
      • Chat with an Expert
      • General Inquiries
      • Editorial Bureaus
      • Partnerships
      • Media Inquiries
      • Worldwide Offices

      Products

      • Explore Our Platform
      • Plan Campaigns
      • Create with AI
      • Distribute Press Releases
      • Report Results
      • Amplify Content

      About

      • About PR Newswire
      • About Cision
      • Careers
      • Accessibility Statement
      • APAC
      • APAC - Simplified Chinese
      • APAC - Traditional Chinese
      • Brazil
      • Canada
      • Czech
      • Denmark
      • Finland
      • France
      • Germany
      • India
      • Indonesia
      • Israel
      • Italy
      • Japan
      • Korea
      • Mexico
      • Middle East
      • Middle East - Arabic
      • Netherlands
      • Norway
      • Poland
      • Portugal
      • Russia
      • Slovakia
      • Spain
      • Sweden
      • United Kingdom
      • Vietnam

      My Services

      • All New Releases
      • Platform Login
      • Data Privacy

      Do not sell or share my personal information:

      • Submit via [email protected] 
      • Call Privacy toll-free: 877-297-8921

      Contact PR Newswire

      Products

      About

      My Services
      • All News Releases
      • Platform Login
      • ProfNet
      Call PR Newswire at
      888-776-0942
      • Terms of Use
      • Privacy Policy
      • Information Security Policy
      • Site Map
      • RSS
      • Cookies
      Copyright © 2026 Cision US Inc.